Andere Sprachen Eli Lilly and Company

Aktien

858560

US5324571083

LLY

Pharmazeutika

Markt geschlossen - Nyse Andere Börsenplätze 22:01:47 13.05.2026			% 5 Tage	Veränd. 1. Jan.
1.015,75 ^USD	+2,61 %		+2,91 %	-5,48 %

13.05.	Takeda plant Abbau von rund 4.500 Stellen im Geschäftsjahr 2026 im Zuge forcierter Restrukturierung	RE
13.05.	US-FDA lässt Medikament von BeOne zur Behandlung einer Blutkrebsart zu	RE

Andere Sprachen

13.05.	Takeda to cut about 4,500 jobs in fiscal 2026 as it steps up restructuring
13.05.	US FDA approves BeOne's drug for a type of blood cancer
13.05.	Analyst recommendations: Nvidia, Microsoft, Boeing, Eli Lilly, Siemens…
13.05.	Wall Street recibe la factura de los precios al por mayor
13.05.	Wall Street Just Got Its Wholesale Receipt
13.05.	Eli Lilly India says Lilly's Alzheimer's drug donanemab is expected to be available in India in May
13.05.	Eli Lilly launches Alzheimer's drug Donanemab in India
13.05.	Eli Lilly India launches Lormalzi for Alzheimer's disease in India
13.05.	Eli Lilly Says Foundayo, Lower-Dose Zepbound Provided Durable Weight-Loss Maintenance in 2 Trials
13.05.	Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds
13.05.	Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
12.05.	In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries
12.05.	Het Ierse fiscale succes versus het risico op afhankelijkheid
12.05.	Il successo fiscale irlandese di fronte al rischio di dipendenza
12.05.	Hims & Hers plunges as branded weight-loss drug pivot hits results
12.05.	Bristol Myers Squibb and China's Hengrui Pharma Forge Tie-Up
12.05.	Roche receives CE mark for new blood test to detect Alzheimer's pathology
12.05.	Roche's Plasma Blood Test Secures CE Mark for Alzheimer's Pathology Detection
12.05.	Roche gets second European approval for Alzheimer's test
11.05.	Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
11.05.	Novo Nordisk to Sell Parkinson's Cell Therapy to Startup Cellular Intelligence
11.05.	NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
11.05.	El éxito fiscal de Irlanda frente al riesgo de dependencia
11.05.	Eli Lilly To Acquire Kelonia Therapeutics
09.05.	Ireland's fiscal success faces the risk of over-reliance